Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Dihematoporphyrin ether clearance in primate bladders.

U O Nseyo, T S Mang, W R Potter

    The Journal of Urology
    |December 1, 1986
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Learning from clinical phenotypes: Low-dose biophotonics therapies in oral diseases.

    Oral diseases·2018
    Same author

    The use of photodynamic therapy using 630nm laser light and porfimer sodium for the treatment of oral squamous cell carcinoma.

    Photodiagnosis and photodynamic therapy·2014
    Same author

    Photodynamic therapy for chest wall recurrence from breast cancer.

    Photodiagnosis and photodynamic therapy·2014
    Same author

    Sequential whole bladder photodynamic therapy treatments: A preclinical study.

    Urologic oncology·2011
    Same author

    Photodynamic inactivation of normal and antifungal resistant Candida species.

    Photodiagnosis and photodynamic therapy·2010
    Same author

    Hypericum perforatum L. extract - novel photosensitizer against human bladder cancer cells.

    Journal of photochemistry and photobiology. B, Biology·2006

    New methods accurately measure dihydroergotamine (DHE) in primate bladders, showing slower bladder clearance than serum. This aids drug dosimetry and photodynamic therapy timing.

    Area of Science:

    • Biomedical Engineering
    • Pharmacology
    • Urology

    Background:

    • Dihydroergotamine (DHE) is a drug used in photodynamic therapy.
    • Accurate measurement of DHE in tissues is crucial for effective treatment.
    • Existing methods for DHE measurement in bladders are limited.

    Purpose of the Study:

    • To evaluate novel techniques for studying DHE uptake and clearance in primate bladders.
    • To establish a quantitative correlation between in vivo fluorescence and extracted DHE.
    • To compare DHE clearance rates in serum and bladder tissue.

    Main Methods:

    • In vivo tissue fluorescence photometry was utilized.
    • Chemical extraction of DHE from bladder tissue was performed.
    • DHE levels were monitored over time in primate serum and bladders.

    Related Experiment Videos

    Main Results:

    • Both fluorescence photometry and chemical extraction proved effective for studying DHE in primate bladders.
    • A quantitative correlation was established between fluorescence readings and extracted DHE concentrations.
    • DHE clearance from the bladder was observed to be slower than from serum, with both processes showing a phasic pattern.

    Conclusions:

    • The developed techniques are suitable for assessing porphyrin pharmacokinetics in primate bladders.
    • These methods can inform drug dosimetry and optimize photoactivation timing for photodynamic therapy.
    • Understanding DHE clearance kinetics is vital for clinical applications of photodynamic therapy.